Literature DB >> 2775765

Human brain gangliosides: developmental changes from early fetal stage to advanced age.

L Svennerholm1, K Boström, P Fredman, J E Månsson, B Rosengren, B M Rynmark.   

Abstract

The developmental profiles of the four major brain gangliosides, GM1, GD1a, GD1b, and GT1b, were examined in human frontal lobe covering the period from 10 fetal weeks to 80 years of age. The ganglioside concentration increased approx. 3-fold from the 10th gestational week to the age of about 5 years. Gangliosides GM1 and GD1a increased 12-15-fold during the same period. The most rapid increase of GM1 and GD1a occurred around term, during the period for dendrite arborization, outgrowth of axons and synaptogenesis. GT1b showed a quite different developmental curve. It was the major ganglioside during the 3rd to 5th gestational month, whereafter its concentration dropped rapidly to term, from which time the concentration then increased up to 50 years of age. Similar curves were found for the other gangliosides of the b-series, GD3, GD2, GD1b and GQ1b. Ganglioside 3'-isoLM1 was a characteristic early fetal ganglioside which dropped rapidly to the 5th gestational month, reached a small peak around term and then disappeared during adulthood. The concentration of gangliosides of the neolacto series was larger than that of the lacto series during the whole developmental period. In the beginning of the second trimester, 3'-LM1 constituted 2% and LD1 10% of total ganglioside sialic acid. The new findings demonstrate more dynamic changes of the ganglioside patterns during development than noted in previous studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2775765     DOI: 10.1016/0005-2760(89)90175-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  66 in total

1.  α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.

Authors:  Atsushi Kobayashi; Tetsuya Hirata; Takashi Nishikaze; Akinori Ninomiya; Yuta Maki; Yoko Takada; Tetsuyuki Kitamoto; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2020-04-22       Impact factor: 5.157

2.  Lactational changes in concentration and distribution of ganglioside molecular species in human breast milk from Chinese mothers.

Authors:  Lin Ma; Xihong Liu; Alastair K H MacGibbon; Angela Rowan; Paul McJarrow; Bertram Y Fong
Journal:  Lipids       Date:  2015-09-24       Impact factor: 1.880

3.  Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.

Authors:  Tadashi Yamashita; Yun-Ping Wu; Roger Sandhoff; Norbert Werth; Hiroki Mizukami; Jessica M Ellis; Jeffrey L Dupree; Rudolf Geyer; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 4.  Brain gangliosides in axon-myelin stability and axon regeneration.

Authors:  Ronald L Schnaar
Journal:  FEBS Lett       Date:  2009-10-12       Impact factor: 4.124

5.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

6.  Activities of glycolipid glycosyltransferases and sialidases during the early development of Xenopus laevis.

Authors:  R Gornati; S Basu; G Bernardini; A M Rizzo; F Rossi; B Berra
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 7.  The glycosphingolipid hydrolases in the central nervous system.

Authors:  Massimo Aureli; Maura Samarani; Nicoletta Loberto; Rosaria Bassi; Valentina Murdica; Simona Prioni; Alessandro Prinetti; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.590

8.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

9.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells.

Authors:  C Hirschmann-Jax; A E Foster; G G Wulf; J G Nuchtern; T W Jax; U Gobel; M A Goodell; M K Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

10.  Sialic acid utilisation and synthesis in the neonatal rat revisited.

Authors:  Peter I Duncan; Frédéric Raymond; Andreas Fuerholz; Norbert Sprenger
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.